CGH
RDY icon

Crossmark Global Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History

Crossmark Global Holdings’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$185K Sell
12,735
-8
-0.1% -$108 ﹤0.01% 1242
2026
Q1 		$176K Sell
12,743
-17
-0.1% -$237 ﹤0.01% 1212
2025
Q4 		$179K Sell
12,760
-1,074
-8% -$15.1K ﹤0.01% 1192
2025
Q3 		$193K Hold
13,834
– – ﹤0.01% 1255
2025
Q2 		$208K Buy
13,834
+439
+3% +$6.27K ﹤0.01% 1259
2025
Q1 		$177K Buy
13,395
+635
+5% +$8.76K ﹤0.01% 1278
2024
Q4 		$201K Sell
12,760
-2,135
-14% -$32.1K ﹤0.01% 1211
2024
Q3 		$237K Sell
14,895
-3,030
-17% -$48.8K ﹤0.01% 1178
2024
Q2 		$273K Sell
17,925
-2,710
-13% -$38.8K 0.01% 1104
2024
Q1 		$303K Buy
20,635
+170
+0.8% +$2.48K 0.01% 1091
2023
Q4 		$285K Buy
20,465
+135
+0.7% +$1.8K 0.01% 1088
2023
Q3 		$271K Buy
20,330
+365
+2% +$4.94K 0.01% 1068
2023
Q2 		$275K Sell
19,965
-160
-0.8% -$1.87K 0.01% 1111
2023
Q1 		$229K Buy
+20,125
New +$217K 0.01% 1167
2022
Q4 		– Sell
-21,115
Closed -$221K – 1273
2022
Q3 		$221K Sell
21,115
-4,635
-18% -$49.4K 0.01% 1131
2022
Q2 		$285K Buy
+25,750
New +$280K 0.01% 1052
2021
Q4 		– Sell
-60,650
Closed -$790K – 1450
2021
Q3 		$790K Sell
60,650
-7,650
-11% -$102K 0.02% 698
2021
Q2 		$1M Buy
68,300
+2,550
+4% +$35.7K 0.02% 611
2021
Q1 		$807K Buy
65,750
+2,850
+5% +$36.6K 0.02% 676
2020
Q4 		$897K Buy
62,900
+4,400
+8% +$59.2K 0.02% 600
2020
Q3 		$814K Sell
58,500
-13,700
-19% -$163K 0.02% 599
2020
Q2 		$765K Buy
+72,200
New +$734K 0.02% 617

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Crossmark Global Holdings's RDY Position: Q2 2026 in Review

Crossmark Global Holdings reduced its Dr. Reddy's Laboratories (RDY) stake by 0.06% in Q2 2026, selling an estimated $108 and leaving 12,735 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Crossmark Global Holdings first reported a position in RDY in Q2 2020 and has held it in 22 quarters since. The position peaked at $1M in Q2 2021. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Crossmark Global Holdings held 12,735 shares of Dr. Reddy's Laboratories worth $185K as of Q2 2026.
  • Crossmark Global Holdings sold 8 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $108.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1242 holding.
  • Crossmark Global Holdings first reported a position in Dr. Reddy's Laboratories in Q2 2020 and has held it in 22 quarters since.
  • Crossmark Global Holdings's Dr. Reddy's Laboratories position peaked at $1M in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.